Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs morphine PCIA for breakthrough pain in postherpetic neuralgia
ChiCTR2200065358Phase 4Not yet recruiting
- Sponsor
- Department of Pain, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in postherpetic neuralgia (PHN) and Neuralgia (2 arms), sponsored by Department of Pain, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Primary endpoints: Number and duration of breakthrough pain episodes, Dosage of rescue analgesic drugs and number of rescue analgesia events and 1 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
postherpetic neuralgia (PHN)Neuralgia
Beyond the preview
Go deeper on ChiCTR2200065358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065358.